Evaxion Biotech Management
Management criteria checks 2/4
Evaxion Biotech's CEO is Christian Kanstrup, appointed in Sep 2023, has a tenure of less than a year. total yearly compensation is $373.00K, comprised of 31.1% salary and 68.9% bonuses, including company stock and options. directly owns 1.41% of the company’s shares, worth $308.09K. The average tenure of the management team and the board of directors is 3.5 years and 2.9 years respectively.
Key information
Christian Kanstrup
Chief executive officer
US$373.0k
Total compensation
| CEO salary percentage | 31.1% |
| CEO tenure | less than a year |
| CEO ownership | 1.4% |
| Management average tenure | 3.5yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration
Mar 31Evaxion Biotech names Per Norlén as CEO
Oct 05Evaxion stock rises 11% as enrollment begins in trial of immunotherapy EVX-01 for skin cancer
Sep 21Evaxion Biotech ADS GAAP EPS of -$0.20 beats by $0.10
Aug 10Evaxion Biotech announces new CEO as Lars Wegner resigns
Aug 02Is Evaxion Biotech (NASDAQ:EVAX) In A Good Position To Invest In Growth?
Oct 27
We're Hopeful That Evaxion Biotech (NASDAQ:EVAX) Will Use Its Cash Wisely
Jun 29Evaxion Biotech posts preclinical proof of concept data for AI-powered vaccine platform
Jun 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$373k | US$116k | -US$22m |
Compensation vs Market: Christian's total compensation ($USD373.00K) is below average for companies of similar size in the US market ($USD677.87K).
Compensation vs Earnings: Insufficient data to compare Christian's compensation with company performance.
CEO
Christian Kanstrup (51 yo)
less than a year
Tenure
US$373,000
Compensation
Mr. Christian Kanstrup, MSc, serves as Chief Executive Officer of Evaxion Biotech A/S since September 01, 2023. He joined Evaxion Biotech A/S on September 01, 2023. He previously served as Executive Vice P...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | US$373.00k | 1.41% $ 308.1k | |
| Co-Founder and Chief AI & Culture Officer | 16.3yrs | US$246.00k | 8.05% $ 1.8m | |
| Interim CFO & COO | 2.1yrs | US$296.00k | 0.070% $ 15.4k | |
| Co-Founder | 16.3yrs | US$124.00k | 8.18% $ 1.8m | |
| Chief Scientific Officer | 2.6yrs | US$336.00k | 0.070% $ 15.4k | |
| Head of Business Development & Member of Advisory Board | 4.5yrs | no data | no data |
3.5yrs
Average Tenure
47yo
Average Age
Experienced Management: EVAX's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 1.9yrs | US$124.00k | 8.18% $ 1.8m | |
| Head of Business Development & Member of Advisory Board | 2.1yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 2.9yrs | US$64.00k | 0.14% $ 30.8k | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Chairwoman of the Board | 3.4yrs | US$193.00k | 1.57% $ 342.3k | |
| Independent Director | 6.3yrs | US$62.00k | 0.77% $ 168.5k |
2.9yrs
Average Tenure
55yo
Average Age
Experienced Board: EVAX's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.